# Citations for Research Query

**Query:** # Disease Pathophysiology Research Template

## Target Disease
- **Disease Name:** Psoriatic Arthritis
- **MONDO ID:**  (if available)
- **Category:** Complex

## Research Objectives

Please provide a comprehensive research report on the pathophysiology of **Psoriatic Arthritis**.
Focus on the molecular and cellular mechanisms underlying disease progression.

### Required Information

#### 1. Core Pathophysiology
- What are the primary pathophysiological mechanisms?
- What molecular pathways are dysregulated?
- What cellular processes are affected?

#### 2. Key Molecular Players
- **Genes/Proteins**: Which genes are causally involved or implicated?
- **Chemical Entities**: What metabolites, drugs, or small molecules are relevant?
- **Cell Types**: Which cell types are primarily affected?
- **Anatomical Locations**: Which tissues/organs are involved?

#### 3. Biological Processes (for GO annotation)
- What biological processes (GO terms) are disrupted?
- Consider: signaling pathways, metabolic processes, cellular responses, transport, etc.

#### 4. Cellular Components
- Where in the cell do key processes occur?
- Consider: organelles, membrane compartments, extracellular space, etc.

#### 5. Disease Progression
- What is the sequence of events from initial trigger to clinical manifestation?
- Are there distinct stages or phases?

#### 6. Phenotypic Manifestations
- What are the key clinical phenotypes?
- How do they relate to the underlying mechanisms?

### Citation Requirements

- Cite primary literature (PMID preferred) for all mechanistic claims
- Prioritize recent reviews and landmark papers
- Include direct quotes where possible to support key statements

### Output Format

Structure your response as a narrative that could be used to populate a disease knowledge base entry with:
- Pathophysiology description
- Gene/protein annotations with ontology terms (HGNC, GO)
- Phenotype associations (HP terms)
- Cell type involvement (CL terms)
- Anatomical locations (UBERON terms)
- Chemical entities (CHEBI terms)
- Evidence items with PMIDs

**Provider:** perplexity
**Generated:** 2026-02-01T09:16:48.037291

1. https://health.ucdavis.edu/news/headlines/new-research-explains-mechanisms-behind-psoriatic-arthritis/2024/01
2. https://www.science.org/doi/10.1126/sciimmunol.adu0284
3. https://pmc.ncbi.nlm.nih.gov/articles/PMC12010266/
4. https://pmc.ncbi.nlm.nih.gov/articles/PMC10003101/
5. https://pmc.ncbi.nlm.nih.gov/articles/PMC8047476/
6. https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2021.672515/full
7. https://pmc.ncbi.nlm.nih.gov/articles/PMC3305829/
8. https://pmc.ncbi.nlm.nih.gov/articles/PMC12086172/
9. https://pmc.ncbi.nlm.nih.gov/articles/PMC4678416/
10. https://csg.sph.umich.edu/abecasis/publications/pdf/J.Invest.Dermatol.vol.132-pp.1133.pdf
11. https://acrjournals.onlinelibrary.wiley.com/doi/10.1002/art.43286?af=R
12. https://psoriasiscouncil.org/research/genetic-meta-analysis-identified-the-biological-mechanisms-of-psoriasis-susceptibility/
13. https://archivesofrheumatology.org/index.php/pub/article/download/1479/2650/2468
14. https://pubmed.ncbi.nlm.nih.gov/2095178/
15. https://pmc.ncbi.nlm.nih.gov/articles/PMC3387493/
16. https://pmc.ncbi.nlm.nih.gov/articles/PMC10828502/
17. https://pmc.ncbi.nlm.nih.gov/articles/PMC8789658/
18. https://www.webmd.com/arthritis/psoriatic-arthritis/psoriatic-arthritis-stages
19. https://www.ncbi.nlm.nih.gov/books/NBK547710/
20. https://www.healthline.com/health/psoriatic-arthritis-stages
21. https://www.the-rheumatologist.org/article/the-heterogeneity-of-psoriatic-arthritis/?singlepage=1
22. https://onlinelibrary.wiley.com/doi/10.1111/exd.12572
23. https://pmc.ncbi.nlm.nih.gov/articles/PMC2656567/
24. https://www.clinexprheumatol.org/article.asp?a=2650
25. https://pmc.ncbi.nlm.nih.gov/articles/PMC153764/
26. https://pmc.ncbi.nlm.nih.gov/articles/PMC4450469/
27. https://www.frontiersin.org/journals/medicine/articles/10.3389/fmed.2019.00014/full
28. https://pubmed.ncbi.nlm.nih.gov/22133017/
29. https://pubmed.ncbi.nlm.nih.gov/21549221/
30. https://pmc.ncbi.nlm.nih.gov/articles/PMC5539937/
31. https://onlinelibrary.wiley.com/doi/10.1155/2019/1824624
32. https://academic.oup.com/ced/article/7/4/387/6632089
33. https://pmc.ncbi.nlm.nih.gov/articles/PMC10728743/
34. https://pmc.ncbi.nlm.nih.gov/articles/PMC5984668/
35. https://pmc.ncbi.nlm.nih.gov/articles/PMC6836300/
36. https://pmc.ncbi.nlm.nih.gov/articles/PMC2911863/
37. https://pmc.ncbi.nlm.nih.gov/articles/PMC6748574/
38. https://onlinelibrary.wiley.com/doi/10.1111/exd.15151
39. https://dpcj.org/index.php/dpc/article/view/5977
40. https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1100869/full
41. https://pmc.ncbi.nlm.nih.gov/articles/PMC3672783/
42. https://pmc.ncbi.nlm.nih.gov/articles/PMC12465665/
43. https://pmc.ncbi.nlm.nih.gov/articles/PMC8400543/
44. https://pmc.ncbi.nlm.nih.gov/articles/PMC7331484/
45. https://pmc.ncbi.nlm.nih.gov/articles/PMC11699830/
46. https://pubmed.ncbi.nlm.nih.gov/14613270/
47. https://pubmed.ncbi.nlm.nih.gov/40528683/
48. https://pmc.ncbi.nlm.nih.gov/articles/PMC11750473/
49. https://acrjournals.onlinelibrary.wiley.com/doi/abs/10.1002/art.11331
50. https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2023.1081256/full
51. https://pmc.ncbi.nlm.nih.gov/articles/PMC2945042/
52. https://pubmed.ncbi.nlm.nih.gov/32159793/
53. https://pmc.ncbi.nlm.nih.gov/articles/PMC7589391/
54. https://pmc.ncbi.nlm.nih.gov/articles/PMC9749424/
55. https://www.archivesofrheumatology.org/index.php/pub/article/download/1479/2651?inline=1
56. https://pmc.ncbi.nlm.nih.gov/articles/PMC11007107/